148 research outputs found
Expression of minichromosome maintenance protein 2 as a marker for proliferation and prognosis in diffuse large B-cell lymphoma: a tissue microarray and clinico-pathological analysis-1
No full text<p><b>Copyright information:</b></p><p>Taken from "Expression of minichromosome maintenance protein 2 as a marker for proliferation and prognosis in diffuse large B-cell lymphoma: a tissue microarray and clinico-pathological analysis"</p><p>BMC Cancer 2005;5():162-162.</p><p>Published online 20 Dec 2005</p><p>PMCID:PMC1343577.</p><p>Copyright © 2005 Obermann et al; licensee BioMed Central Ltd.</p>Kaplan-Meier method). (IHC = immunohistochemistry
Expression of minichromosome maintenance protein 2 as a marker for proliferation and prognosis in diffuse large B-cell lymphoma: a tissue microarray and clinico-pathological analysis
No full textAbstract Background Minichromosome maintenance (MCM) proteins are essential for the initiation of DNA replication and have been found to be relevant markers for prognosis in a variety of tumours. The aim of this study was to assess the proliferative activity of diffuse large B-cell lymphoma (DLBCL) in tissue microarray (TMA) using one of the minichromosome maintenance proteins (Mcm2) and to explore its potential value to predict prognosis. Methods Immunohistochemistry for Mcm2 was performed on TMAs constructed from 302 cases of DLBCL. A monoclonal mouse antibody was used after heat induced antigen retrieval. Mcm2 expression was scored quantitatively. Positivity for Mcm2 was defined as presence of nuclear expression of Mcm2 in greater than or equal to 40 % of tumour cells. A statistical analysis was carried out of the association of Mcm2 and the clinico-pathological characteristics. Results Mcm2 expression was clearly evident in the nuclei of proliferating non-neoplastic cells and tumour cells. Positivity for Mcm2 was found in 46% (98/211) of analysable cases. A significant correlation existed between Mcm2 expression and presence of bulky disease (p = 0.003). Poor disease specific survival was observed in patients with DLBCL positive for Mcm2 expression in the univariate analysis (p = 0.0424). Conclusion Mcm2 expression can be used to assess tumour proliferation and may be useful as an additional prognostic marker to refine the prediction of outcome in DLBCL.</p
Expression of minichromosome maintenance protein 2 as a marker for proliferation and prognosis in diffuse large B-cell lymphoma: a tissue microarray and clinico-pathological analysis-0
No full text<p><b>Copyright information:</b></p><p>Taken from "Expression of minichromosome maintenance protein 2 as a marker for proliferation and prognosis in diffuse large B-cell lymphoma: a tissue microarray and clinico-pathological analysis"</p><p>BMC Cancer 2005;5():162-162.</p><p>Published online 20 Dec 2005</p><p>PMCID:PMC1343577.</p><p>Copyright © 2005 Obermann et al; licensee BioMed Central Ltd.</p>e zone are positive for Mcm2. Figure 1B: Immunohistochemical staining of Mcm2 in diffuse large B-cell lymphoma. This case is positive for Mcm2-expression with more than 40% of tumour cells expressing this marker
Cell cycle phase distribution analysis in chronic lymphocytic leukaemia: a significant number of cells reside in early G1-phase.
No full textBackground and Aims: Chronic lymphocytic leukaemia (CLL) is a frequent non-Hodgkin lymphoma characterised by a heterogeneous clinical course. Assessment of cell cycle phase kinetics might be important for prediction of clinical behaviour and prognosis. Methods: Distribution of neoplastic cells in CLL within the cell cycle was evaluated by determining the labelling indices (LI, i.e. percentage of positive cells) of markers specific for late G1-phase (cyclin E), S-phase (cyclin A), and G2/M-phase (cyclin B1), and Mcm2, a novel marker of proliferative potential, in a large cohort of patients (n = 79) using tissue microarray (TMA) technology. Utilising a combination of these markers, an algorithm was developed-subtracting the combined LIs of cyclin E, cyclin A and cyclin B1 from the LI of Mcm2-to determine the percentage of tumour cells residing in early G1-phase, which is probably a critical state for the malignant potential of CLL. Results: 27.11% of cells had acquired proliferative potential as indicated by expression of Mcm2. Only a small number of cells were found to be in late G1-phase (7.16%), S-phase (3.31%) or G2/M-phase (0.98%), while 15.66% of cells were considered to be in early G1-phase. Conclusion: Cell cycle phase distribution can easily be assessed by immunohistochemistry in routinely processed paraffin-embedded specimens. A large number of neoplastic cells in CLL have proliferative potential, with a significant sub-population residing in early G1-phase. Estimates of these cells may identify cases likely to exhibit a more aggressive biological behaviour and adverse clinical course
Abstract 2962: Mechanobiology of epithelia on native basement membrane and relevance for cancer invasion
No full textAbstract
The onset of metastasis occurs when cancer cells invade and breach the basement membrane (BM) that provides mechanical support to epithelial tissues. Yet, it remains unclear what triggers cancer cells to breach the BM, and how ‘triggered’ cells in fact breach the BM. We have established an in vitro assay using native BM interface for culturing epithelial cells. Using atomic force microscopy (AFM) with other high-resolution microscopies and TER (trans-epithelial resistance), we have correlated the mechano-cellular attributes of the BM/epithelium interface to its biochemical and structural properties. We demonstrated that the internal limiting membrane (ILM) isolated from human retinas acts as a native substrate for culturing epithelial cells in terms of BM composition, architecture and stiffness. These are required to act jointly in order to achieve apico-basal polarity, tissue barrier formation and stiffness properties of the epithelial layer similarly to secretory epithelia in vivo. The native BM serves several advantageous over reconstituted Matrigel, an ECM extracts that originates from mouse tumor ascites. Besides variations in thickness and biochemical composition, we find that Matrigel is mechanically 100-fold more compliant (i.e., softer) than native BMs. When tumorigenic variants of cells are used, we demonstrated that cancer cell invasion is associated with a decrease in cellular stiffness correlated to changes in cell and BM morphology. In addition, we showed that activation of ß1 integrin by the stiffness and architecture of the native alpha - 5 laminin chain has a key role, not only as previously thought for maintenance of cell polarity but also for the establishment of a physiological mechanophenotype. On the other hand it is well know that during cancer progression in vivo, cancer cells can perforate the BM using proteolysis. Whether stromal cells also play a role and what kind of role in this process is unclear. Therefore, we asked if carcinoma-associated fibroblasts (CAFs) isolated from cancer patients promote cancer cell invasion through a BM. In the presence of CAFs, moderately invasive cancer cells invade in a matrix metalloproteinase-independent manner. Using live imaging and atomic force microscopy, we showed that CAFs actively pull, stretch and soften the BM, forming gaps through which cancer cells can migrate. By exerting contractile forces, CAFs alter the organization and the physical properties of the BM, making it permissive for cancer cell invasion. Finally, we propose that, in addition to proteolysis, mechanical interactions between CAFs and BM represent an alternative mechanism of BM breaching. Given their mechano-biological relevance, native BMs allow us to further understand how mechanosignaling occurs between the epithelia and the surrounding stromal layers at the BM interface during cancer invasion and progression.
Note: This abstract was not presented at the meeting.
Citation Format: Marija Plodinec, Philipp Oertle, Daphne Assgeirson, Willi Halfter, Serenella Eppenberger Castori, Ellen C. Obermann, Alexandre Glentis, Roderick Y. LIM. Mechanobiology of epithelia on native basement membrane and relevance for cancer invasion [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2017; 2017 Apr 1-5; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2017;77(13 Suppl):Abstract nr 2962. doi:10.1158/1538-7445.AM2017-2962</jats:p
- …
